1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
2026 SURF/STAR program orientation May 26, 2026; Summer Symposium July 31, 2026. No specific application deadline for DRPP faculty grants stated.
Rhode Island IDeA Network of Biomedical Research Excellence (RI-INBRE) is sponsored by National Institutes of Health (NIH). The RI-INBRE program, funded by NIH, expands statewide research capacity in biomedical sciences, including cancer. This recent award supports equipment, workforce development, and recruitment of biomedical researchers and scientists in Rhode Island academic institutions.
Get alerted about grants like this
Get emailed when new opportunities from “National Institutes of Health (NIH)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Rhode Island IDeA Network of Biomedical Research Excellence – (RI-INBRE) 2026 WDT Registration is Open.
Event Date Time and Location Registration 2026 SURF/STAR Orientation May 26, 2026 9:30 AM – 4:00 PM 2026 RI-INBRE Annual Retreat June 26, 2026 1:30 PM – 3:30 PM Avedesian 240 Invitation Only 2026 Undergraduate Experience Day and Picnic June 26, 2026 9:00 AM – 3:00 PM 2026 Workforce Development and Training Panel Discussion July 15, 2026 12:00 PM – 2:00 PM Avedesian 240 2026 Summer Undergraduate Research Symposium (SURS) July 31, 2026 9:00 AM – 12:30 PM Link The Rhode Island IDeA Network of Biomedical Research Excellence (RI-INBRE) program is a statewide network designed to build the biomedical research capacity of Rhode Island institutions, by supporting and developing talented individuals committed to biomedical research careers in Rhode Island.
Research conducted under the RI-INBRE Developmental Research Project Program ( DRPP ) spans the breadth of biomedical sciences, including psychology, biomedical engineering, cancer biology, microbiology, microplastics, neurodegenerative diseases, cardiovascular health, and biomedical data science.
RI-INBRE hosts manages two core facilities for data acquisition and data analysis, the Centralized Research Core Facility ( CRCF ) and the Molecular Informatics Core ( MIC ). The SURF & STAR programs under the Training Core provide valuable research training experiences for undergraduate students.
The Institutional Development Award (IDeA) Network of Biomedical Research Excellence (INBRE) is designed to provide funding for building research capacity in selected states.
The guiding principles in organizing this Network for the development of biomedical sciences research in Rhode Island are to: Facilitate and increase the number of junior investigators and to prepare them to successfully compete for independent extramural funding from the NIH and other funding agencies Increase the number of students being trained for careers in the biomedical sciences Provide access to instrumentation and bioinformatics core facilities for conducting cutting-edge research Please direct any comments or questions regarding the RI-INBRE Program to riinbre@etal.
uri. edu Explore and Apply for Research Funding for Faculty Undergraduate, Graduate, and Faculty Fellowships RI Summer Undergraduate Research Symposium As Rhode Island’s flagship public research university, I am so proud to have INBRE’s home right here at URI, and I am proud that our work is being recognized at the federal level. It’s a true collaboration between all our colleges and universities.
URI President Marc Parlange The ten participating research institutions are the University of Rhode Island , Brown University , Bryant University , Johnson and Wales University , Providence College , Rhode Island College , Roger Williams University , Salve Regina University , Community College of Rhode Island and The New England Institute of Technology .
RI-INBRE is based at the University of Rhode Island and is located at the College of Pharmacy .
According to the current listing, eligibility includes: Academic institutions and researchers (undergraduate, graduate, faculty) at the ten Rhode Island institutions in the RI-INBRE network. Confirm the full requirements in the official notice before applying.
Rhode Island IDeA Network of Biomedical Research Excellence (RI-INBRE) is funded by National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
This opportunity targets applicants in Rhode Island. If your organization operates elsewhere, check the official notice for location requirements.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
PAR-27-054 and PAR-27-055 replace COBRE's Phase 1-2-3 model with two tracks: a 15-year Development-Expansion-Sustainability path and a 10-year Expansion-Sustainability path. At $1.5 million per year in direct costs across 23 states and Puerto Rico, with new research cores prohibited in the final phase and eligibility capped at three active awards per institution, the track you claim is the most consequential choice in the application.
Read articleNOT-OD-26-112 released a draft NIH Biosafety Policy for Research Involving Biohazards on August 19, 2026. It would replace the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules, extend IBC jurisdiction from engineered molecules to wild-type agents, toxins and prions, impose 24-hour incident reporting, and make the Biosafety Officer a federally defined role. Here is what actually changes and how to respond before the October 19, 2026 deadline.
Read articleNIH released a draft policy on August 27, 2026 that would require every NIH-supported clinical study to offer participants a plain-language summary of results — clinical trials within one year of completion, all other clinical research by the end of the funding period. It covers observational and behavioral research that ClinicalTrials.gov never touched. Here is the scope, the four requirements nobody has budgeted for, and what to say before the October 26 deadline.
Read article